Results 1 to 10 of about 2,628,190 (315)

Acknowledgment to reviewers of Reviews in Cardiovascular Medicine in 2020 [PDF]

open access: yesReviews in Cardiovascular Medicine, 2021
No abstract present.
Reviews in Cardiovascular Medicine Editorial Office
doaj   +1 more source

Acknowledgment to the Reviewers of Journal of Cardiovascular Development and Disease in 2022

open access: yesJournal of Cardiovascular Development and Disease, 2023
High-quality academic publishing is built on rigorous peer review [...]
Journal of Cardiovascular Development and Disease Editorial Office
doaj   +1 more source

Social Determinants of Cardiovascular Risk, Subclinical Cardiovascular Disease, and Cardiovascular Events

open access: yesJournal of the American Heart Association, 2023
Background Although there is research on the impact of social determinants of health (SDOHs) on cardiovascular health, most existing evidence is based on individual SDOH components. We evaluated the impact of cumulative SDOH burden on cardiovascular risk factors, subclinical atherosclerosis, and incident cardiovascular disease ...
Isaac Acquah   +14 more
openaire   +3 more sources

Acknowledgment to Reviewers of Journal of Cardiovascular Development and Disease in 2021

open access: yesJournal of Cardiovascular Development and Disease, 2022
Rigorous peer-reviews are the basis of high-quality academic publishing [...]
Journal of Cardiovascular Development and Disease Editorial Office
doaj   +1 more source

Editorial: Insights in cardiovascular therapeutics: 2021 – cell death, cardiovascular injuries, and novel targets of cardiovascular therapeutics

open access: yes, 2022
With the effort and support of the authors, editorial office, and editorial team, the Frontiers in Cardiovascular Medicine, Cardiovascular Therapeutics Section-Research Topic “Insights in Cardiovascular Therapeutics: 2021” has achieved great success and ...
Vazquez-Padron, Roberto I.   +13 more
core   +1 more source

SGLT2 inhibitors - a breakthrough in treatment of heart failure and their multipotential beneficial role in cardiology, diabetology, nephrology and neurology

open access: yesJournal of Education, Health and Sport, 2023
Inhibitors of the sodium-glucose cotransporter 2 (SGLT2 inhibitors) are relatively new and innovative antihyperglycemic drugs which by inhibiting sodium-glucose cotransporter 2 minimalise reabsorption of glucose in nephrones.
Marta Bogowska   +9 more
doaj   +1 more source

Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies [PDF]

open access: yes, 2011
BACKGROUND: Guidelines differ about the value of assessment of adiposity measures for cardiovascular disease risk prediction when information is available for other risk factors. We studied the separate and combined associations of body-mass index (BMI),
Nordestgaard, Borge G.   +75 more
core   +1 more source

Cardiovascular Metabolomics [PDF]

open access: yesCirculation Research, 2018
Disturbances in cardiac metabolism underlie most cardiovascular diseases. Metabolomics, one of the newer omics technologies, has emerged as a powerful tool for defining changes in both global and cardiac-specific metabolism that occur across a spectrum of cardiovascular disease states.
Robert W, McGarrah   +4 more
openaire   +2 more sources

Jorge Luis Simon

open access: yesRevista del Hospital de Niños, 2023
Homenaje póstumo y recuerdo. Al Dr.
Cirugia Cardiovascular Cardiologia
doaj   +2 more sources

C-Reactive Protein, Fibrinogen, and Cardiovascular Disease Prediction [PDF]

open access: yes, 2012
BACKGROUND: There is debate about the value of assessing levels of C-reactive protein (CRP) and other biomarkers of inflammation for the prediction of first cardiovascular events.
Iso, Hiroyasu   +438 more
core   +1 more source

Home - About - Disclaimer - Privacy